Your browser doesn't support javascript.
loading
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study.
Mujukian, Angela; Kumar, Rashmi; Li, Dalin; Debbas, Philip; Botwin, Gregory J; Cheng, Susan; Ebinger, Joseph; Braun, Jonathan; McGovern, Dermot; Melmed, Gil Y.
Affiliation
  • Mujukian A; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Kumar R; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Li D; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Debbas P; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Botwin GJ; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Cheng S; Smidt Heart Institute, Department of Medicine, Cedars-Sinai, Los Angeles, CA, USA.
  • Ebinger J; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Braun J; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • McGovern D; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
  • Melmed GY; Inflammatory Bowel and Immunobiology Research Institute, Karsh Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Inflamm Bowel Dis ; 30(4): 602-616, 2024 Apr 03.
Article in En | MEDLINE | ID: mdl-37556401
Those with inflammatory bowel disease (IBD) reported fewer postvaccination symptoms relative to non-IBD health care workers. Local and systemic symptoms were generally mild and lasted less than 2 days in both populations. The data are reassuring with considerable vaccine hesitancy.
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 / BNT162 Vaccine Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 / BNT162 Vaccine Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Male Language: En Journal: Inflamm Bowel Dis Journal subject: GASTROENTEROLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: